Report of Mr. Amresh Kshirsagar PDF
Report of Mr. Amresh Kshirsagar PDF
Glycosylated hemoglobin (hemoglobin A1c, HbA1c, A1C, or Hb1c; sometimes also HbA1c) is a form of hemoglobin used primarily to identify the
average plasma glucose concentration over prolonged periods of time. It is formed in a non-enzymatic pathway by hemoglobin's normal exposure
to high plasma levels of glucose. Glycation of hemoglobin has been associated with cardiovascular disease, nephropathy and retinopathy in
diabetes mellitus. Monitoring the HbA1c in type-1 diabetic patients may improve treatment. HbA1c is a weighted average of blood glucose levels
during the preceding 120 days, which is the average life span of red blood cells. A large change in mean blood glucose can increase HbA1c levels
within 1-2 weeks. Sudden changes in HbA1c may occur because recent changes in blood glucose levels contribute relatively more to the final
HbA1c levels than earlier events. For instance, mean blood glucose levels in the 30 days immediately preceding blood sampling contribute 50% to
the HbA1c level, whereas glucose levels in the preceding 90-120 day period contribute only 10%. Thus, it does not take 120 days to detect a
clinically meaningful change in HbA1c following a significant change in mean plasma glucose level.
CREATININE
Test Result Unit Biological Ref. Range
Creatinine : 0.94 mg/dl 0.6-1.4
LIPID PROFILE
Test Result Unit Reference Range
Total Cholesterol : 156.7 mg/dl Desirable :- < 200
Borderline High : 200 - 239
Undesirable :- > 240
TEST : Troponin -T
RESULT : Negative